Experience with directly observed prophylaxis using erythromycin in military trainees exposed to pertussis

Military Medicine

Volumn 169, Issue 6, 2004, Pages 417-420

  Purcell, Bret K ^a,b   Dooley, David P ^a   Gray, Paula J ^a   Hill, Kathi J ^a   Oliverson, Forrest W ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN;

ADULT; ARMY; ARTICLE; CASE REPORT; DIARRHEA; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HOSPITAL ADMISSION; HUMAN; NAUSEA; PATIENT COMPLIANCE; PERTUSSIS; PROPHYLAXIS; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SOLDIER; TREATMENT FAILURE; VOMITING; ANTIBIOTIC PROPHYLAXIS; DIRECTLY OBSERVED THERAPY; INTERVIEW; OCCUPATIONAL EXPOSURE; UNITED STATES;

ADULT; ANTIBIOTIC PROPHYLAXIS; DIRECTLY OBSERVED THERAPY; ERYTHROMYCIN; FEMALE; HUMANS; INTERVIEWS; MILITARY PERSONNEL; OCCUPATIONAL EXPOSURE; UNITED STATES; WHOOPING COUGH;

EID: 4344599163     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.169.6.417     Document Type: Article

References (18)

1. Pazzaglia G, Pasternack M: Pneumonia morbidity in U.S. Naval personnel during 1970-1979. J Infect Dis 1982; 145: 766.
2. Pazzaglia G, Pasternack M: Recent trends of pneumonia morbidity in U.S. Naval personnel. Milit Med 1983; 148: 647-51.
3. Mogabagab WJ: Mycoplasma pneumoniae and adenovirus respiratory illness in military and university personnel. 1959-1966. Am Rev Respir Dis 1968; 97: 345-58.
4. Amundson DE, Weiss PJ: Pneumonia in military recruits. Milit Med 1994; 15: 629-31.
5. Steketee RW, Wassilak SG, Adkins WN, Burstyn DG, Manclark CR, Berg J, Hopfensperger D, Schell WL, Davis JP: Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 1988; 157: 434-40.
6. ACIP: Recommendation of the Immunization Practices Advisory Committee. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Morb Mortal Wkly Rep 1985; 34: 405-26.
7. Dodhia H, Miller E: Review of the evidence for the use of erythromycin in the management of persons exposed to pertussis. Epidemiol Infect 1998; 120: 143-9.
8. Halperin SA, Bortolussi R, Langley JM, Miller B, Eastwood BJ: Erythromycin chemoprophylaxis in household contacts of children with pertussis, Dalhousie University and the IWK-Grace Health Centre, Halifax, Nova Scotia, Canada and the University of Auckland, New Zealand. Abstract number K94. Thirty-Sixth Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, September 15-18, 1996.
9. Saloranta P, Roos L, Elonen E, Allonen H: Erythromycin ethylsuccinate, base and acistrate in the treatment of upper respiratory tract infections: two comparative studies of tolerability. J Antimicrob Chemother 1989; 24: 455-62.
10. Gordin A, Kalima S, Hulmi S, Makela P, Antikainen R: Comparison of erythromycin acistrate and enterocoated erythromycin base in acute respiratory infections. J Antimicrob Chemother 1988; 21(Suppl D): 85-92.
11. Gordin A, Salmi HA, Antikainen R: Erythromycin acistrate and enterocoated pellets of erythromycin base in acute respiratory infections of hospitalized conscripts. J Antimicrob Chemother 1988; 21(Suppl D): 93-9.
12. Rostila T, Visa K, Gordin A, Antikainen R: Erythromycin acitrate and erythromycin stearate in the treatment of non-gonococcal urethritis. J Antimicrob Chemother 1988; 21(Suppl D): 113-9.
13. Christopher FL, Hepburn MJ, Frolichstein RA: Pertussis in a military and military beneficiary population: case series and review of the literature. Milit Med 2002; 167: 215-8.
14. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR: The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881-4.
15. Washington JA, Wilson WR: Erythromycin: a microbial and clinical perspective after 30 years of clinical use. First of two parts. Mayo Clin Proc 1985; 60: 189-203.
16. Davis MS: Variations in patients' compliance with doctors' orders: analysis of congruence between survey responses and results of empirical investigations. J Med Ed 1966; 41: 1037-48.
17. Martinez SM, Kemper CA, Haiduven D, Cody SH, Deresinski SC: Azithromycin prophylaxis during a hospital-wide outbreak of a pertussis-like illness. Infect Control Hosp Epidemiol 2001; 22: 781-3.
18. Mortensen JE, Rogers GL: In vitro activity of gemifloxacin and other antimicrobial agents against isolates of Bordetella pertussis and Bordetella parapertussis. J Antimicrob Chemother 2000; 45(Suppl 1): 47-9.